CV Risk Reduction and
Glycemic Control in TD2
Focus on GLP-1 RAs and Combination Insulin FormulationsLearn More >
Supported by an educational grant from Roche Singapore Pte Ltd.
Optimizing Glycemic Regulation
Through Combination Therapy
Focus on the Safety, Convenience, Metabolic Effects, HA1c Control, Complementarity, and Dfficacy of Combination Basal Insulin-GLP-1 RA Regimens for FPG and PPG Control.Learn More >
Supported by an educational grant from Sanofi Diabetes
Rheumatoid Arthritis (RA)
Focus on IL-Inhibitors for Optimizing Multimodal Management of RA.
A Year 2017 Science-to-Best Practice Roadmap for the RA Specialist
World Authorities on Rheumatoid Arthritis Answer FAQs and Outline Treat-to-Target Strategies for 2017 and Beyond.
Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals
iQ&A interactive Medical Intelligence Zone welcomes your questions and your participation in the iQ&A community.
iQ&A (interactive Medical Intelligence) welcomes your questions and your participation in the iQ&A community.